| Also known as |
LGD-4033, VK5211 |
| Blood pressure |
Potential to increase blood pressure, though not commonly reported |
| Chemical name |
4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile |
| Dosage (medical) |
Not medically approved for any conditions yet, clinical trials typically used dosages between 0.1 mg to 1 mg per day |
| Dosage (sports) |
Commonly 5 mg to 10 mg per day |
| Effects |
Increases lean body mass, improves physical function and strength |
| Formula |
C14H12F6N2O |
| Half-life |
24 to 36 hours |
| Hepatotoxicity |
Low potential but not well studied |
| Lab Test |
View |
| Main action |
Increases muscle mass and strength |
| Raw Material |
Ligandrol |
| Side effects |
May include fatigue, headache, nausea, potential long-term effects on hormone levels and liver health unknown due to lack of long-term studies |
| Storage conditions |
Store at room temperature away from moisture and direct sunlight |
| Substance class |
Selective Androgen Receptor Modulator (SARM) |
| Trade name |
Ligandrol |
| Use in sports |
Used by athletes and bodybuilders to enhance muscle growth and performance |
| Water Retention |
Minimal |
| Manufacturer |
INTEX PHARMA |
| Packing |
60 tabs (10 mg/tab) |
